Based on recent data, Dr. Reddy's Laboratories Limited (RDY) shows an Average True Range (ATR) of 0.27 and an Enterprise Value of 997.1B. Its average trading volume over the past 3 months is 2.42M, indicating liquidity. These fundamental metrics provide insight into RDY's underlying financial health and market activity.
| ATR | 0.27 |
| Enterprise Value | 997.1B |
| Avg Vol (3 Months) | 2.42M |
| Avg Vol (10 Days) | 1.28M |
Dr. Reddy's Laboratories Limited (RDY) technical indicators as of June 12, 2026: the SMA 20 is 2.91%, SMA 50 at 4.93%, and SMA 200 at 2.17%. The RSI 14 value is 62.34, suggesting its current momentum. These technical analysis signals help assess RDY's price trends and potential future movements.
| SMA 20 | 2.91% |
| SMA 50 | 4.93% |
| SMA 200 | 2.17% |
| RSI 14 | 62.34 |
Dr. Reddy's Laboratories Limited (RDY) stock performance overview as of June 12, 2026: The 52-week high is $15.97 (currently -9.83% below), and the 52-week low is $12.19 (currently 18.92% above). Over the past year, RDY's performance is -12.74%, compared to the S&P 500's 9.67% change.
| 52-Week High | 15.97 |
| 52-Week High Chg | -9.83% |
| 52-Week Low | 12.19 |
| 52-Week Low Chg | +18.92% |
| S&P 500 52-Week Chg | 9.67% |
According to market data, Dr. Reddy's Laboratories Limited (RDY) stock's recent performance metrics show that over the last month, RDY is -7.11%, with a Year-to-Date (YTD) performance of -7.83%. Over the past year, the stock has seen a -12.74% change. These figures summarize RDY's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 13.47 | 13.9 | 14.61 | 14.8 | 15.97 | 14.8 |
| Low | 13.11 | 12.19 | 12.19 | 12.19 | 12.19 | 12.19 |
| Performance | -4.01% | -7.11% | -10.45% | -11.07% | -12.74% | -7.83% |
According to current financial data, RDY stock's P/E (TTM) ratio is 24.95, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for RDY, including P/S (3.17), P/B (2.90), and P/FCF (44.00), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | RDY | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | 24.95 | -1.22 | 13.14 | 32.59 |
| P/S (TTM) | 3.17 | 3.69 | 6.11 | 5.98 |
| P/B (TTM) | 2.9 | 3.71 | 66.62 | 5.14 |
| P/FCF (TTM) | 44 | -5.69 | 4.24 | 29.06 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep